Markets continue falling

The markets continued falling during the midday with the Dow plummeting 148 points to 17,561. Nasdaq tumbled 41 points to 4,734.

On the upside

Top Image Systems (Nasdaq: TISA) reported higher first quarter revenue.

The Patent Trial and Appeal Board sided with Coherus BioSciences (Nasdaq: CHRS) by agreeing to review AbbVie's (NYSE: ABBV) patent on the arthritis treatment Humira.

Second quarter earnings slipped for Cemtrex (Nasdaq: CETX) but revenue climbed.

On the downside

Red Robin Gourmet Burgers (Nasdaq: RRGB) reported lower first quarter earnings as revenue fell short of expectations prompting the casual dining chain to lower its full year forecast.

Aegerion Pharmaceuticals (Nasdaq: AEGR) widened first quarter losses more than expected as revenue tumbled prompting the company to cut its full year revenue outlook.

Oclaro (Nasdaq: OCLR) will present at several upcoming investor conferences.

In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 4 on the NYSE and by more than 3 to 2 on Nasdaq. The broader S&P 500 fell 9 points to 2,056. Bitcoin edged up a fraction to $454.